BCL2L1 and neoplasm: After the critical stage (stage IIB), signaling receptor genes (IL4R) were highly expressed, which might have triggered the phosphorylation of PI3K and AKT proteins and further upregulated the expression of the apoptosis inhibitor BCL2L1 and enhanced tumor cell growth and proliferation.